References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Strøbaeketal(2006)InhibitorygatingmodulationofsmallconductanceCa2+-activatedK+channelsbythesyntheticcompound(R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine(NS8593)reducesafterhyperpolarizingcurrentinhipMol.Pharmacol.701771PMID:16926279
Sørensen(2008)Synthesisandstructure-activityrelationshipstudiesof2-(N-substituted)-aminobenzimidazolesaspotentnegativegatingmodulatorsofsmallconductanceCa2+-activatedK+channels.J.Med.Chem.517625PMID:18998663
Jenkinsetal(2011)Negativegatingmodulationby(R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine(NS8593)dependsonresiduesintheinnerporevestibule:pharmacologicalevidenceofdeep-poregatingofKCa2channels.Mol.Pharmacol.79899PMID:21363929
Keywords:NS8593hydrochloride,supplier,NS8593,hydrochloride,selective,Kca2,SK,small,channels,conductance,calcium,ca2+,activated,potassium,K+,modulators,inhibits,inhibitors,Ca2+-Activated,Potassium,Channels,Ca2+-Activated,Potassium,Channels,TocrisBioscience